71 related articles for article (PubMed ID: 19447252)
1. Short neuroprotective peptides, ADNF9 and NAP, are structurally disordered and monomeric in PBS.
Arakawa T; Niikura T; Arisaka F; Kita Y
Int J Biol Macromol; 2009 Jul; 45(1):8-11. PubMed ID: 19447252
[TBL] [Abstract][Full Text] [Related]
2. Activity-dependent neurotrophic factor, ADNF, determines the structure characteristics of Colivelin, a fusion protein of ADNF9 and Humanin analog.
Arakawa T; Niikura T; Arisaka F; Kita Y
J Pept Sci; 2008 May; 14(5):631-6. PubMed ID: 17994638
[TBL] [Abstract][Full Text] [Related]
3. Structure analysis of activity-dependent neurotrophic factor 9 by circular dichroism and sedimentation equilibrium.
Arakawa T; Niikura T; Tajima H; Arisaka F; Kita Y
J Mol Neurosci; 2007; 33(3):262-7. PubMed ID: 17952635
[TBL] [Abstract][Full Text] [Related]
4. The secondary structure analysis of a potent Ser14Gly analog of antiAlzheimer peptide, Humanin, by circular dichroism.
Arakawa T; Niikura T; Tajima H; Kita Y
J Pept Sci; 2006 Oct; 12(10):639-42. PubMed ID: 16835886
[TBL] [Abstract][Full Text] [Related]
5. The structure analysis of Humanin analog, AGA-(C8R)HNG17, by circular dichroism and sedimentation equilibrium: comparison with the parent molecule.
Arisaka F; Niikura T; Arakawa T; Kita Y
Int J Biol Macromol; 2008 Aug; 43(2):88-93. PubMed ID: 18456318
[TBL] [Abstract][Full Text] [Related]
6. NAP, a peptide derived from the activity-dependent neuroprotective protein, modulates macrophage function.
Quintana FJ; Zaltzman R; Fernandez-Montesinos R; Herrera JL; Gozes I; Cohen IR; Pozo D
Ann N Y Acad Sci; 2006 Jul; 1070():500-6. PubMed ID: 16888216
[TBL] [Abstract][Full Text] [Related]
7. Peptide antagonists of ethanol inhibition of l1-mediated cell-cell adhesion.
Wilkemeyer MF; Menkari CE; Spong CY; Charness ME
J Pharmacol Exp Ther; 2002 Oct; 303(1):110-6. PubMed ID: 12235240
[TBL] [Abstract][Full Text] [Related]
8. The biological activity of Humanin analogs correlates with structure stabilities in solution.
Arakawa T; Niikura T; Kita Y
Int J Biol Macromol; 2011 Jul; 49(1):93-7. PubMed ID: 21510972
[TBL] [Abstract][Full Text] [Related]
9. Active form of neuroprotective Humanin, HN, and inactive analog, S7A-HN, are monomeric and disordered in aqueous phosphate solution at pH 6.0; No correlation of solution structure with activity.
Arisaka F; Arakawa T; Niikura T; Kita Y
Protein Pept Lett; 2009; 16(2):132-7. PubMed ID: 19200035
[TBL] [Abstract][Full Text] [Related]
10. AL-108 and AL-208, formulations of the neuroprotective NAP fragment of activity-dependent neuroprotective protein, for cognitive disorders.
Geerts H
Curr Opin Investig Drugs; 2008 Jul; 9(7):800-11. PubMed ID: 18600585
[TBL] [Abstract][Full Text] [Related]
11. Stable right- and left-handed peptide helices containing C(alpha)-tetrasubstituted alpha-amino acids.
Grauer AA; Cabrele C; Zabel M; König B
J Org Chem; 2009 May; 74(10):3718-26. PubMed ID: 19354242
[TBL] [Abstract][Full Text] [Related]
12. Cationic oligopeptides with the repeating sequence L-lysyl-L-alanyl-L-alanine: conformational and thermal stability study using optical spectroscopic methods.
Setnicka V; Hlavácek J; Urbanová M
J Pept Sci; 2009 Aug; 15(8):533-9. PubMed ID: 19579212
[TBL] [Abstract][Full Text] [Related]
13. The microtubule interacting drug candidate NAP protects against kainic acid toxicity in a rat model of epilepsy.
Zemlyak I; Manley N; Vulih-Shultzman I; Cutler AB; Graber K; Sapolsky RM; Gozes I
J Neurochem; 2009 Dec; 111(5):1252-63. PubMed ID: 19799711
[TBL] [Abstract][Full Text] [Related]
14. Neurotrophic effects of the peptide NAP: a novel neuroprotective drug candidate.
Gozes I; Spivak-Pohis I
Curr Alzheimer Res; 2006 Jul; 3(3):197-9. PubMed ID: 16842095
[TBL] [Abstract][Full Text] [Related]
15. Three-dimensional structure of the two-peptide bacteriocin plantaricin JK.
Rogne P; Haugen C; Fimland G; Nissen-Meyer J; Kristiansen PE
Peptides; 2009 Sep; 30(9):1613-21. PubMed ID: 19538999
[TBL] [Abstract][Full Text] [Related]
16. Affinity-based screening of peptides recognizing assembly states of self-assembling peptide nanomaterials.
Sawada T; Takahashi T; Mihara H
J Am Chem Soc; 2009 Oct; 131(40):14434-41. PubMed ID: 19764764
[TBL] [Abstract][Full Text] [Related]
17. Nerve growth factor from Vipera lebetina venom.
Paalme V; Trummal K; Samel M; Tõnismägi K; Järvekülg L; Vija H; Subbi J; Siigur J; Siigur E
Toxicon; 2009 Sep; 54(3):329-36. PubMed ID: 19463841
[TBL] [Abstract][Full Text] [Related]
18. Ability of GHTD-amide and analogs to enhance insulin activity through zinc chelation and dispersal of insulin oligomers.
Paule SG; Nikolovski B; Ludeman J; Gray RE; Spiccia L; Zimmet PZ; Myers MA
Peptides; 2009 Jun; 30(6):1088-97. PubMed ID: 19463741
[TBL] [Abstract][Full Text] [Related]
19. Reversible self-assembly: a key feature for a new class of autodelivering therapeutic peptides.
Pertinhez TA; Conti S; Ferrari E; Magliani W; Spisni A; Polonelli L
Mol Pharm; 2009; 6(3):1036-9. PubMed ID: 19366260
[TBL] [Abstract][Full Text] [Related]
20. Peripheral nerve at extreme low temperatures 1: effects of temperature on the action potential.
Stecker MM; Baylor K
Cryobiology; 2009 Aug; 59(1):1-11. PubMed ID: 19558975
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
